表紙:アフィニトール薬の世界市場(2021年~2027年)
市場調査レポート
商品コード
1064654

アフィニトール薬の世界市場(2021年~2027年)

Global Afinitor Drug Market 2021-2027

出版日: | 発行: Orion Market Research | ページ情報: 英文 85 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
アフィニトール薬の世界市場(2021年~2027年)
出版日: 2022年01月27日
発行: Orion Market Research
ページ情報: 英文 85 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアフィニトール薬の市場規模は、予測期間中にかなりのCAGRで成長すると予測されています。当市場を牽引する主な要因には、臓器移植の数のかなりの増加と癌などの慢性疾患の発生率の上昇などがあります。

当レポートではアフィニトール薬市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、タイプ別、用途別、地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 市場の決定要因

  • 促進要因
  • 抑制要因
  • 市場機会

第4章 市場細分化

  • 世界のアフィニトール薬市場:タイプ別
    • 2.5Mg
    • 5Mg
    • 7mg
    • 10Mg
  • 世界のアフィニトール薬市場:用途別
    • 病院
    • ドラッグストア
    • その他

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他アジア太平洋地域
  • その他の地域

第6章 企業プロファイル

  • Novartis AG
  • Teva Pharmaceuticals
図表

LIST OF TABLES

  • 1. GLOBAL AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL 2.5 MG AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL 5 MG AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL 7 MG AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL 10 MG AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 7. GLOBAL AFINITOR DRUG FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL AFINITOR DRUG FOR DRUG STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL AFINITOR DRUG FOR OTHER APPLICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 11. NORTH AMERICAN AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 12. NORTH AMERICAN AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 13. NORTH AMERICAN AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 14. EUROPEAN AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 15. EUROPEAN AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 16. EUROPEAN AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 17. ASIA-PACIFIC AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 18. ASIA-PACIFIC AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 19. ASIA-PACIFIC AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 20. REST OF THE WORLD AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 21. REST OF THE WORLD AFINITOR DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL AFINITOR DRUG MARKET SHARE BY TYPE, 2020 VS 2027 (%)
  • 2. GLOBA AFINITOR DRUG MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 3. GLOBAL AFINITOR DRUG MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 4. US AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 5. CANADA AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. UK AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. FRANCE AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. GERMANY AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. ITALY AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. SPAIN AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. REST OF EUROPE AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. INDIA AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. CHINA AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. JAPAN AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. REST OF THE WORLD AFINITOR DRUG MARKET SIZE, 2020-2027 ($ MILLION)
目次
Product Code: OMR2024133

Global Afinitor Drug Market Size, Share & Trends Analysis Report By Type (2.5 Mg, 5 Mg, 7 Mg, and 10 Mg), By Application (Hospitals, Drug Stores, Others), Forecast (2021 - 2027)

The global afinitor drug market is anticipated to grow at a considerable CAGR during the forecast period. The considerable increase in the number of organ transplants and rising incidences of chronic diseases such as cancer are some key creating demand for the afinitor drug market. According to the US Health Resources and Services Administration, in 2020, nearly 39,000 organ transplants were performed in the US.

The global afinitor drug market is segmented based on type and application. Based on type, the afinitor drug market is segmented into 2.5 Mg, 5 Mg, 7 Mg, and 10 Mg. Based on application, the afinitor drug market is segmented into hospitals, drug stores, and others.

Geographically, the global afinitor drug market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global afinitor drug market include Novartis International AG, Teva Pharmaceuticals Industries Ltd., and more.

Market Segmentation

1. Global Afinitor Drug Market Research and Analysis by Type

2. Global Afinitor Drug Market Research and Analysis by Application

The Report Covers

  • Comprehensive research methodology of the global afinitor drug market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global afinitor drug market.
  • Insights about market determinants that are stimulating the global afinitor drug market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global Afinitor Drug Market by Type
    • 4.1.1. 2.5 Mg
    • 4.1.2. 5 Mg
    • 4.1.3. 7 Mg
    • 4.1.4. 10 Mg
  • 4.2. Global Afinitor Drug Market by Application
    • 4.2.1. Hospitals
    • 4.2.2. Drug Stores
    • 4.2.3. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Novartis AG
  • 6.2. Teva Pharmaceuticals